{
    "root": "294580cb-5622-4f48-89a8-99000a7a2964",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "Human Prescription Drug Label",
    "name": {
        "text": "ambrisentan"
    },
    "value": "20250430",
    "ingredients": [
        {
            "name": "AMBRISENTAN",
            "code": "HW6NV07QEC"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "LECITHIN, SOYBEAN",
            "code": "1DI56QDM62"
        },
        {
            "name": "POLYVINYL ALCOHOL, UNSPECIFIED",
            "code": "532B59J990"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3350",
            "code": "G2M7P15E5P"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        }
    ],
    "indications": "Ambrisentan is indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) in adult patients:  \n                      • To improve exercise ability and delay clinical worsening.\n                      Studies establishing effectiveness included predominantly patients with WHO Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%).",
    "contraindications": "• Initiate treatment at 5 mg once daily (2.1). • Titrate at 4-week intervals as needed and tolerated (2.1). • Do not split, crush, or chew tablets (2.1).",
    "warningsAndPrecautions": "Ambrisentan film-coated tablets are supplied as follows:\n                  \n                  \n                     \n                        \n                        \n                        \n                        \n                     \n                     \n                        \n                           \n                              Tablet Strength\n                              \n                           \n                           \n                              Package Configuration\n                              \n                           \n                           \n                              NDC No.\n                              \n                           \n                           \n                              Description of Tablet; Debossed on Tablet\n                              \n                           \n                        \n                        \n                           5 mg\n                           \n                           30 count carton (3 x 10 unit-dose)\n                           \n                           47335-236-64\n                           \n                           round biconvex; pale pink; debossed with “236” on one side and plain on the other side.\n                           \n                        \n                        \n                           \n                              30 count bottle\n                           47335-236-83\n                           \n                        \n                        \n                           \n                              10 count bottle\n                           \n                               47335-236-85\n                        \n                        \n                           10 count carton (1 x 10 unit-dose)\n                           \n                           47335-236-66\n                           \n                        \n                        \n                           10 mg\n                           \n                           30 count carton (3 x 10 unit-dose)\n                           \n                           47335-237-64\n                           \n                           Oval biconvex; deep pink; debossed with “237” on one side and plain on the other side.\n                           \n                        \n                        \n                           30 count bottle\n                           \n                           47335-237-83\n                           \n                        \n                        \n                           \n                              10 count bottle\n                           \n                              47335-237-85\n                        \n                        \n                           10 count carton (1 x 10 unit-dose)\n                           \n                           47335-237-66\n                           \n                        \n                     \n                  \n                  \n                   Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° and 30°C (59° and 86°F). [see USP Controlled Room Temperature]. Store ambrisentan in its original packaging.",
    "adverseReactions": "• Pregnancy (4.1) • Idiopathic Pulmonary Fibrosis (4.2)"
}